We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Plexpress Announces Collaboration with Admescope
News

Plexpress Announces Collaboration with Admescope

Plexpress Announces Collaboration with Admescope
News

Plexpress Announces Collaboration with Admescope

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Plexpress Announces Collaboration with Admescope"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Plexpress has announced a new collaboration with the contract research organisation (CRO), Admescope, which will now include TRAC as part of its services for investigating in vitro drug interactions and pre-clinical ADME-Tox responses.

Admescope customers can now take advantage of the benefits offered by Plexpress’ novel TRAC (Transcript Analysis with the aid of Affinity Capture) technology.

These include higher sample throughput, increased assay speed and reduced technical variation when compared to similar gene expression analyses undertaken using qPCR or microarrays.

In the first instance, Admescope will offer Plexpress’ well-validated multiplex assays targeting the Cytochrome P450 (CYP) family, which can be used as an insightful indicator of potential drug toxicity and efficacy.

The new service is particularly well suited to meeting recent draft recommendations from the FDA, which suggest that CYP mRNA analysis might be more informative for drug metabolism studies than measuring CYP activity.

Advertisement